Dialysis
261 results
50 - 149
migALAstat- alfacalcidol
Renal Replacement Therapy- rucaparib
- calcitriol (systemic)
- ruxolitinib (systemic)
- adefovir
- darbepoetin
- Drug-Induced Adverse Renal Interactions/Reactions
- Ascites
- alatrofloxacin
- trovafloxacin
- ferric carboxymaltose
- fesoterodine
- vericiguat
- peginesatide
- tenapanor
- enoxacin
- hydroxyurea
- telotristat ethyl
- Autoimmune Pulmonary Disorders
Anesthesia for Transplant Surgery - Anesthesia for Kidney Transplantation- sucroferric oxyhydroxide
- Azotemia
- denosumab
- nevirapine
- Specific Considerations With Renal Disease - Renal Failure
Methicillin-resistant Staphylococcus aureus (MRSA)- imipenem/cilastatin/relebactam
- Acid-Base Disorders
- mirabegron
- eluxadoline
- pirfenidone
- Ethylene Glycol, Methanol, Propylene Glycol, and Isopropyl Alcohol Ingestion
- Pancreatic Transplant, Immediate Postoperative Care
- iron sucrose
- ixazomib
- ferric pyrophosphate citrate
- Salicylate Overdose
- piperacillin/tazobactam
- Digoxin
- calcium carbonate
- aprotinin
- Oliguria
- fluconazole
- ticarcillin/clavulanate
- Commonly Prescribed Drug Overdoses
- Percutaneous Enteral Feeding Access
- Acute Renal Failure
- Peritonitis
- captopril
- pomalidomide
- levETIRAcetam
- prucalopride
- levocarnitine
- cinacalcet
- sparfloxacin
- Vascular Access - Vascular Access Devices
- carglumic acid
- methoxy polyethylene glycol-epoetin beta
- phentermine/topiramate
- lesinurad
- romosozumab
- oseltamivir
- crizotinib
- dolutegravir
- epoetin alfa
- panobinostat
- eptifibatide
- Acute Kidney Injury (AKI)
- Evaluating the Patient Before Anesthesia - Anesthetic Assessment and Plan
- simeprevir
- riociguat
- daprodustat
- difelikefalin
- norfloxacin
- Glomerulonephritis
- Acute Tumor Lysis Syndrome (ATLS)
- Acute Interstitial Nephritis
- budesonide/formoterol/glycopyrrolate
- prucalopride succinate
- vardenafil
- colchicine
- Non-Operating Room Anesthesia - Anesthesia for Gastrointestinal/Genitourinary and Vascular Radiology Procedures
- Acute Hemolytic Anemia
- potassium acid phosphate
- empagliflozin/linagliptin
- tofacitinib
- RISKS OF GADOLINIUM-BASED MRI INTRAVENOUS CONTRAST AGENTS